PONOI CAPITAL, LP's Net Worth
$217 Million
Who is PONOI CAPITAL, LP?
PONOI CAPITAL, LP has an estimated net worth of $217 Million. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., NGM BIOPHARMACEUTICALS INC, CONSTELLATION PHARMACEUTICALS INC, Revolution Medicines, Inc., RAPT Therapeutics, Inc., Nurix Therapeutics, Inc., and Arcus Biosciences, Inc..
SEC CIK
PONOI CAPITAL, LP's CIK is 0001707230
Past Insider Trading and Trends
2019 was PONOI CAPITAL, LP's most active year for acquiring shares with 60 total transactions. PONOI CAPITAL, LP's most active month to acquire stocks was the month of April. 2021 was PONOI CAPITAL, LP's most active year for disposing of shares, totalling 58 transactions. PONOI CAPITAL, LP's most active month to dispose stocks was the month of August. 2019 saw PONOI CAPITAL, LP paying a total of $62,465,985.21 for 24,146,787 shares, this is the most they've acquired in one year. In 2020 PONOI CAPITAL, LP cashed out on 17,877,849 shares for a total of $104,799,656.90, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMMUNE DESIGN CORP. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.64M |
$5.85 | -$38,861,210.70 |
0
|
Apr 2
| |||
Form 4
| +67.67% | 2.68M |
$4.10 | $10,992,100.00 | 6.64M |
Oct 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CONSTELLATION PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.16% | -10.00K |
$36.95 | -$369,503.00 | 99.16K |
Feb 17
| |||
Form 4
| +1.18% | 30.11K |
$1.55 | $46,665.85 | 2.58M |
Dec 14
| |||
Form 4
| +0.69% | 41.67K |
$22.48 | $936,929.15 | 6.05M |
Mar 19 - Mar 20
| |||
Form 4
| +29.68% | 1.41M |
$8.50 | $11,999,994.00 | 6.17M |
Oct 3
| |||
Form 4
| +42,946.73% | 4.75M |
—
|
—
| 4.76M |
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Revolution Medicines, Inc. (RVMD) Snapshot price: $29.97
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -30.68% | -2.03M |
$36.40 | -$73,788,478.40 | 4.58M |
Nov 16
| |||
Form 4
|
∞
| 7.23K |
—
|
—
| 7.23K |
Feb 12 - Jun 17
| |||
Form 4
|
∞
| 7.98M |
—
|
—
| 7.98M |
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nurix Therapeutics, Inc. (NRIX) Snapshot price: $8.297
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -43.68% | -2.68M |
—
|
—
| 3.45M |
May 5
| |||
Form 4
| +8,007.09% | 6.67M |
—
|
—
| 6.76M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcus Biosciences, Inc. (RCUS) Snapshot price: $14.87
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.54M |
—
|
—
| 3.54M |
Mar 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||